CRISPR Therapeutics $2.4 Billion Cash: Why the Stock Slump Persists
CRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Zero based budgeting can greatly benefit families by promoting better financial health and communication. Find out how to implement it effectively.
19,336 articlesCRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
The latest weekly data shows a spike in initial claims, but the broader labor market remains resilient. Analysts warn...
JPMorgan Chase has set a bold 7% net interest income growth goal for 2026. This article explains why the target could...
Imagine a blockbuster SpaceX IPO that raises $75 billion and pays banks a record underwriting fee. This article break...
Whatnot has crossed a historical milestone: one billion orders processed on its live-commerce platform, fueling a $11...
Ethereum sits at the crossroads of finance and technology. This guide explains whether now is the right time to add E...
When a top executive sells nearly 5,000 shares of Alpha and Omega Semiconductor, investors pause. This article breaks...
When the AI rally paused, investors turned to dependable dividend names. Johnson Johnson, Altria, and Verizon led gai...
Investors poured into bitcoin ETFs this week, reversing prior outflows as appetite for regulated crypto exposure retu...
Eight straight weeks of spot XRP ETF inflows contrast with a falling XRP price, signaling institutional support that ...
What makes a dividend stock truly worth holding forever? This guide dives into two magnificent dividend stocks worth ...
In June, Lemonade stock surged about 12% as investors weighed progress on its reinsurance strategy and AI-driven grow...